GO:0097638 L-arginine import across plasma membrane

L-arginine import across plasma membrane (GO:0097638) is a biological process defined as the directed movement of L-arginine from outside of a cell, across the plasma membrane, and into the cytosol. This process is fundamental for supplying cells with L-arginine, a semi-essential amino acid that serves as a building block for protein synthesis and as a precursor for nitric oxide, polyamines, and creatine. Because L-arginine is charged and hydrophilic, it cannot diffuse freely across the lipid bilayer; instead, its import relies on specific membrane transporters that couple substrate recognition to conformational changes. Researchers study this process to understand how cells adapt to changing nutrient environments and how transport dysfunction contributes to human disease. The molecular details of L-arginine import have been illuminated by structural and computational studies of cationic amino acid transporter 1 (CAT-1), which belongs to the SLC7A family. These studies reveal that substrate binding triggers a series of structural rearrangements that allow L-arginine to traverse the membrane while maintaining the permeability barrier. In parallel, work in yeast has shown that arginine import and export across the vacuolar membrane are coordinated with nitrogen status, highlighting the evolutionary conservation of arginine transport regulation. Together, these findings establish L-arginine import as a critical node in cellular metabolism and a promising target for therapeutic modulation.

In simple terms, GO:0097638 describes how cells take up L-arginine from their surroundings. The QuickGO definition states: 'The directed movement of L-arginine from outside of a cell, across the plasma membrane and into the cytosol.' This process is a type of amino acid import that is specific for the L-isomer of arginine. It requires a transporter protein embedded in the plasma membrane that recognizes L-arginine, binds it, and facilitates its passage into the cell. The process is distinct from arginine export or from transport across organellar membranes, as it specifically refers to movement across the plasma membrane into the cytosol.

L-arginine import across the plasma membrane is essential for maintaining intracellular L-arginine pools that support protein synthesis, nitric oxide signaling, and polyamine metabolism. Because many cancer cells and immune cells have elevated demands for L-arginine, understanding how this import process is regulated can reveal vulnerabilities for therapeutic targeting. Moreover, defects in arginine transport have been linked to cardiovascular disorders and metabolic diseases, underscoring its clinical relevance. In microorganisms, coordinated arginine import and export are critical for nitrogen homeostasis, as demonstrated in yeast where vacuolar arginine transport is adjusted to nitrogen availability.

The following genes encode proteins that directly mediate or regulate L-arginine import across the plasma membrane, as supported by published literature.

L-arginine import across the plasma membrane is regulated at multiple levels. In yeast, the import and export of arginine across the vacuolar membrane are coordinated with nitrogen availability, ensuring that cytosolic arginine levels are maintained within an optimal range. In mammalian cells, the expression and activity of cationic amino acid transporters are modulated by amino acid availability, hormones, and stress signals. For example, the kinase GCN2 senses amino acid deprivation and triggers adaptive responses that can include changes in transporter expression. Additionally, the mTOR pathway, which promotes protein synthesis when amino acids are plentiful, is influenced by intracellular arginine levels. This interplay ensures that L-arginine import matches cellular demand for protein synthesis, nitric oxide production, and other metabolic pathways.

Many cancer cells exhibit increased L-arginine uptake to support rapid proliferation and survival. Upregulation of CAT-1 (SLC7A1) has been observed in various tumors and is associated with poor prognosis. Targeting arginine transport or depriving tumors of L-arginine is being explored as a therapeutic strategy.

L-arginine is the substrate for endothelial nitric oxide synthase (eNOS), which produces nitric oxide to regulate vascular tone. Impaired L-arginine import can reduce nitric oxide bioavailability, contributing to endothelial dysfunction and hypertension.

Arginine metabolism is critical for immune cell function. Myeloid-derived suppressor cells can deplete extracellular L-arginine via arginase, limiting T cell proliferation. Modulating L-arginine import in immune cells may have therapeutic potential in cancer and autoimmune diseases.

Defects in arginine transport or metabolism can lead to hyperargininemia and related metabolic imbalances. Understanding the import process helps in diagnosing and managing such conditions.

Radiolabeled L-arginine uptake assays are used to measure import activity directly. Cells are incubated with [3H]-L-arginine, and uptake is quantified by scintillation counting. This method allows determination of kinetic parameters such as Km and Vmax.

Computational approaches, such as molecular dynamics simulations, provide atomic-level insights into the conformational changes of transporters like CAT-1 during L-arginine translocation. These simulations complement experimental structures and can predict the effects of mutations.

CRISPR-based knockout screens can identify genes required for L-arginine import. Cells are transduced with a genome-wide sgRNA library and cultured in low-arginine conditions; sgRNAs that confer a growth disadvantage are depleted, revealing essential transporters.

Mass spectrometry-based proteomics can quantify transporter abundance, while fluorescence microscopy of tagged transporters reveals their subcellular localization and trafficking.

Researchers studying L-arginine import across plasma membrane-related genes often need to determine whether a candidate gene is causally involved in transport, metabolism, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this research, from gene knockout to precise point mutations and library screening.

L-arginine import across plasma membrane (GO:0097638) is a fundamental biological process that supplies cells with a critical amino acid for protein synthesis, nitric oxide production, and polyamine metabolism. The transporters that mediate this process, particularly the CAT/SLC7A family, are subject to complex regulation and are implicated in cancer, cardiovascular disease, and immune dysfunction. Advances in structural biology and computational simulations have provided detailed mechanistic insights into how these transporters recognize and translocate L-arginine. In yeast, the coordination of arginine import and export with nitrogen status highlights the evolutionary importance of regulating this process. Continued research using CRISPR-based models and high-throughput screening will further elucidate the roles of L-arginine import in health and disease, potentially leading to new therapeutic strategies.